|
|
||||||||

*
Ludwig Institute for Cancer Research, University of Lausanne, Epalinges, Switzerland; and
Swiss Institute for Experimental Cancer Research, Epalinges, Switzerland
We have established H-2Dd-transgenic (Tg) mice, in which H-2Dd expression can be extinguished by Cre recombinase-mediated deletion of an essential portion of the transgene (Tg). NK cells adapted to the expression of the H-2Dd Tg in H-2b mice and acquired reactivity to cells lacking H-2Dd, both in vivo and in vitro. H-2Dd-Tg mice crossed to mice harboring an Mx-Cre Tg resulted in mosaic H-2Dd expression. That abrogated NK cell reactivity to cells lacking Dd. In Dd single Tg mice it is the Ly49A+ NK cell subset that reacts to cells lacking Dd, because the inhibitory Ly49A receptor is no longer engaged by its Dd ligand. In contrast, Ly49A+ NK cells from Dd x MxCre double Tg mice were unable to react to Dd-negative cells. These Ly49A+ NK cells retained reactivity to target cells that were completely devoid of MHC class I molecules, suggesting that they were not anergic. Variegated Dd expression thus impacts specifically missing Dd but not globally missing class I reactivity by Ly49A+ NK cells. We propose that the absence of Dd from some host cells results in the acquisition of only partial missing self-reactivity.
This article has been cited by other articles:
![]() |
T. Grigoryan, P. Wend, A. Klaus, and W. Birchmeier Deciphering the function of canonical Wnt signals in development and disease: conditional loss- and gain-of-function mutations of {beta}-catenin in mice Genes & Dev., September 1, 2008; 22(17): 2308 - 2341. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Coudert, L. Scarpellino, F. Gros, E. Vivier, and W. Held Sustained NKG2D engagement induces cross-tolerance of multiple distinct NK cell activation pathways Blood, April 1, 2008; 111(7): 3571 - 3578. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Back, A. Chalifour, L. Scarpellino, and W. Held Stable masking by H-2Dd cis ligand limits Ly49A relocalization to the site of NK cell/target cell contact PNAS, March 6, 2007; 104(10): 3978 - 3983. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Scarpellino, F. Oeschger, P. Guillaume, J. D. Coudert, F. Levy, G. Leclercq, and W. Held Interactions of Ly49 Family Receptors with MHC Class I Ligands in trans and cis J. Immunol., February 1, 2007; 178(3): 1277 - 1284. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. B. Voyle, F. Beermann, R. K. Lees, J. Schumann, J. Zimmer, W. Held, and H. R. MacDonald Ligand-dependent Inhibition of CD1d-restricted NKT Cell Development in Mice Transgenic for the Activating Receptor Ly49D J. Exp. Med., April 7, 2003; 197(7): 919 - 925. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |